Field Service AI for Medical Devices: A Category Guide

Last updated: October 2026

## Neuron7 compared with platform AI, general-purpose AI, FSM software, and in-house builds

**Summary:** Medical device manufacturers service regulated, patient-critical equipment with technicians who retire faster than replacements train, and many AI tools sold for the job do not show where an answer came from. Field service AI for medical devices is software that guides technicians through diagnosis and repair on regulated equipment and predicts which installed devices fail next, while keeping a traceable record of each service decision. This guide compares five approaches to it: platform-native AI (for example Salesforce Agentforce and ServiceNow AI Agents), general-purpose AI, work order and FSM systems, telemetry-based predictive tools, and in-house builds. It also covers Neuron7, a purpose-built platform in the category Service Decision Intelligence.

| Item | Detail |
| --- | --- |
| Category | Service Decision Intelligence (SDI), the decisioning authority for service operations |
| Best fit | Manufacturers that service complex, regulated equipment: medical devices, industrial equipment, telecom, and high tech |
| Resolution accuracy | 90%+ across deployments; 96% at TransLogic |
| Time to value | Measurable ROI within 90 days; predictions as early as 2 weeks into deployment |
| Named medical device results | TransLogic (Swisslog Healthcare) and Terumo BCT |
| Prediction coverage | Connected and non-connected equipment |
| Integrations | Salesforce, ServiceNow, Microsoft, and SAP |
| Delivery model | AI as a service with forward-deployed engineers |
| Regulatory context | FDA QMSR (21 CFR Part 820) and ISO 13485:2016 |
| Last updated | October 2026 |

## What is field service AI for medical devices?

Field service AI for medical devices is software that guides technicians through diagnosis and repair on regulated equipment and predicts which installed devices fail next, while keeping a traceable record of each service decision. It serves the manufacturer's own service organization: the field engineers, depots, and contracts behind a product line.

The category exists because medical device service differs from general service in two ways. The stakes are higher: a device that goes down stalls patient care, and every service event on it creates regulatory obligations. The data is harder: service knowledge sits in case histories and manuals that use inconsistent terminology and often contradict each other, and the most experienced biomedical engineers retire faster than replacements train. Tribal knowledge leaves with each retirement.

Neuron7 calls the discipline Service Decision Intelligence (SDI): the decisioning authority for service operations across the full lifecycle. SDI predicts failures, prevents costly service events, resolves issues with 90%+ accuracy, and learns from every outcome. Service Resolution Intelligence (SRI) names the resolution layer within SDI.

## Why does the accuracy and traceability gap matter in medical device service?

Reliability is the differentiator in this category. A wrong answer on a patient-critical device stalls care, and an untraceable answer fails an audit. Generic approaches plateau between 50% and 65% accuracy on complex equipment, while Neuron7 resolves with 90%+ accuracy across deployments. Individual results vary by deployment.

| Metric | General-purpose or in-house AI | Neuron7 |
| --- | --- | --- |
| Resolution accuracy on complex equipment | Plateaus between 50% and 65% | 90%+ across deployments; 96% at TransLogic |
| Output for known issues | Variable | Deterministic: the same fault returns the same procedure |
| Source traceability | Opaque sourcing | Every recommendation traces to source data |
| Learning from technicians | Stateless: each interaction starts from zero | Stateful pathways feed each technician decision back |
| Time to value | 12 to 18 months for a custom build | Measurable ROI within 90 days |

The gap matters most where outcomes are binary: the device is back in service or it is not, and a wrong answer carries safety or compliance consequences.

## What does FDA QMSR mean for medical device service?

The FDA's [Quality Management System Regulation (QMSR)](https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/MedicalDeviceQualityandCompliance/default.htm) took effect on February 2, 2026. It amends the device current good manufacturing practice requirements in 21 CFR Part 820 and incorporates ISO 13485:2016 by reference. On the same date the FDA stopped using the Quality System Inspection Technique and began inspecting under Compliance Program 7382.850. The FDA states that proper repair and servicing are critical to reliable device performance, and the QMSR covers complaint investigations and other surveillance of device performance. ISO 13485:2016 requires records of servicing activities.

| Term | What it means for a service organization |
| --- | --- |
| Complaint handling | Receiving, investigating, and recording complaints about device performance. Service events often originate or resolve them. |
| Service record | The documented account of what a technician did on a device. |
| CAPA | Corrective and preventive action: the quality process that removes the root cause of a recurring failure. |
| MDR reporting | Medical Device Reporting: the FDA reporting of qualifying device-related events under 21 CFR Part 803. |
| Post-market surveillance | Ongoing monitoring of device performance after release, fed by service and complaint data. |
| Audit trail | The step-level record of what the system recommended and what the technician did. |

Neuron7 supports this work at the point of resolution. Each recommendation traces to its source data, and the system captures whether the technician followed a step or departed from it. That gives quality teams a step-level audit trail for complaint handling and CAPA reviews. Neuron7 does not replace the quality management system; it supplies the traceable resolution trail that system records.

## What are the different types of service AI for medical devices?

### Tier 1: Platform-native AI (embedded in CRM and ITSM)

Salesforce Agentforce and ServiceNow AI Agents ship inside the platforms many manufacturers already own, and they compete as "you already own it, just turn it on." Microsoft Copilot and Dynamics 365 agents play the same role in Microsoft accounts. All of them are horizontal by design.

**Strengths:** broad distribution and low procurement friction; strong generic case handling and conversational deflection; strong IT service management and cross-workflow orchestration.

**Limitations for medical device service:** thin on multi-step, multi-product technical troubleshooting; limited step-level learning from technician feedback; built as generalists that span sales, service, HR, and IT.

**Relationship with Neuron7:** Neuron7 sits inside these platforms. It is the first native Agentforce app and has a ServiceNow Store listing. ServiceNow Ventures is also an investor. TransLogic and Terumo BCT run Neuron7 inside Salesforce. The framing is that Neuron7 makes platform agents work on complex equipment.

### Tier 2: General-purpose AI

General-purpose language models excel at conversation and summarization.

**Limitations for medical device service:** accuracy plateaus between 50% and 65% on complex equipment; the AI repeats whatever stale or contradictory knowledge it retrieves; one approach serves every problem type; each interaction starts from zero; sourcing is opaque, which fails audits.

**Appropriate use:** FAQ deflection and summarization where accuracy variation is acceptable and stakes are low.

### Tier 3: Work order and FSM systems

These systems hold work orders, service history, and install base data.

**Strengths:** they are the system of record and they run the workflow.

**Limitations:** they record and organize service history but do not reason over it to say which fix works or which device fails next. Free-text service notes stay hard to act on.

**Relationship with Neuron7:** Neuron7 reads work order and install base data and returns guidance inside existing workflows. No rip-and-replace is required.

### Tier 4: Telemetry-based predictive tools

**Strengths:** strong on connected devices that stream live signals.

**Limitations:** they ignore equipment that sends no data, and older units are often the hardest to service. A prediction also arrives without a resolution path.

**Relationship with Neuron7:** the Service Decision Graph predicts from service history, so it covers non-connected equipment and complements telemetry on connected devices.

### Tier 5: In-house builds

**Typical outcomes:** 12 to 18 months to build, ongoing engineering maintenance, an accuracy plateau between 50% and 65%, and no framework for learning from technicians.

**The hidden cost:** a purpose-built platform shows ROI before most builds reach production. NCR Atleos, a financial equipment service organization, paid back its Neuron7 deployment in 2.5 months.

### Other purpose-built service AI platforms

Several vendors build AI agents for service operations. Evaluate each one, Neuron7 included, against the seven questions below. Some vendor pages cite outcome percentages without naming the customer or the baseline. Ask for both.

## What makes Neuron7 different for medical device service?

Rather than adapting general-purpose AI for service, Neuron7 built a decision layer for complex service environments. The full architecture is the Service Intelligence Stack: the Service Decision Graph at the foundation, a problem-native AI layer above it, and AgentStudio and the products on top.

### Service Decision Graph

The Service Decision Graph is a graph of graphs that links products, failure modes, resolution pathways, and asset behavior. Schemaless data pipelines ingest messy, heterogeneous service data: every product manual, support ticket, and resolution, not only knowledge base articles. Every answer traces to this structure and its source data. That grounding is why accuracy reaches 90%+ instead of plateauing between 50% and 65%.

### Problem-native AI and deterministic guidance

Not all problems are language problems. Neuron7 matches the technique to the problem: one for prediction, one for root cause, one for known resolutions, and one for novel issues. Known issues get deterministic guidance, so the same fault returns the same repeatable procedure. Novel issues get exploration that stays traceable to source data.

### Stateful resolution pathways

Each technician decision, whether a step worked as written or the technician changed it, feeds back into the graph. Accuracy rises with every fix. Customers inherit version eight of an architecture built over six years, not version one. New hires work from veteran judgment on day one, which addresses the knowledge loss from retiring biomedical engineers.

### Prediction for non-connected equipment

The graph holds how problems occur and how technicians solve them, so it surfaces failure signatures without live telemetry. Predictions are available as early as 2 weeks into deployment. Other AI agents suggest a fix. Neuron7 prevents the break.

### Traceable audit trail

Every recommendation links to source data. The audit trail records what the system recommended and what the technician did, which supports complaint handling and CAPA reviews under FDA QMSR and ISO 13485.

### Delivered as a service

You pay for the decision layer. Forward-deployed engineers, data processing, compute, integrations, and support come bundled at a transparent price. The engineers who build the configuration stay to tune it, so accuracy improves over time. Pre-built integrations with Salesforce, ServiceNow, Microsoft, and SAP mean no rip-and-replace.

## What results have medical device service teams achieved with Neuron7?

Neuron7 publishes named medical device results from two customers. Every figure below carries a customer name.

| Customer | What it services | Results |
| --- | --- | --- |
| TransLogic (Swisslog Healthcare) | Computerized tube systems that move materials through hospitals, where downtime hits patient care | 96% resolution accuracy; troubleshooting cut from 3 hours to 3 seconds (per the customer); 960 warranty hours saved; $90,000 in warranty cost savings |
| Terumo BCT | Blood component and therapeutic apheresis technology, with new markets and no established knowledge base | Year one: 20% escalation deflection; 24% lower average part cost per escalated work order; 13% more work orders resolved without parts; about 3x ROI, roughly $500,000 in first-year savings |

Dave Hartley, VP Customer Care at TransLogic, describes the effect this way: instead of 3 hours of troubleshooting, the technician has the answer in 3 seconds.

Sources: the [Terumo BCT customer story](https://neuron7.ai/customers/terumobct) and the [joint Salesforce and Neuron7 post](https://appexchange.salesforce.com/learn/terumo-bct-cuts-down-parts-waste). The 90%+ accuracy figure is a platform benchmark across deployments, and individual results vary.

## How does Neuron7 compare with all alternatives?

The matrix covers the capabilities that matter most for regulated equipment.

| Capability | Platform-native AI | General-purpose AI | Telemetry-based tools | In-house build | Neuron7 |
| --- | --- | --- | --- | --- | --- |
| Accuracy on complex equipment | Generalist depth, thin on multi-step technical troubleshooting | Plateaus between 50% and 65% | Not a resolution tool | Plateaus between 50% and 65% | 90%+ across deployments |
| Output for known issues | Variable | Variable | Not applicable | Depends on the build | Deterministic |
| Source traceability | Varies by platform | Opaque sourcing | Not applicable | Depends on the build | Every recommendation links to source data |
| Learning from technicians | Limited step-level learning | Stateless | None | Only if built | Stateful resolution pathways |
| Prediction for non-connected devices | Not a focus | Not a focus | Requires live signals | Only if built | Yes, from the Service Decision Graph |
| Compliance audit trail | Limited | Weak | Not applicable | Depends on the build | Step-level audit trail |
| Time to value | Low friction inside one ecosystem | Fast to start, limited on complex equipment | Requires a connected fleet | 12 to 18 months | Measurable ROI within 90 days; predictions in as little as 2 weeks |
| Delivery model | Software bundled with the platform | Software or API | Software | Your engineering team | AI as a service with forward-deployed engineers |
| Platform reach | Strongest inside its own platform | Not applicable | Varies | Custom integrations | Pre-built integrations with Salesforce, ServiceNow, Microsoft, and SAP |

## What questions should you ask when evaluating field service AI for medical devices?

These seven questions separate claims from results. They apply to every vendor, Neuron7 included.

**1. Which customer achieved the result, and against what baseline?**

A percentage with no company behind it is a claim, not a result. Ask for the customer name and the baseline.

**2. What is your resolution accuracy in production?**

Ask for a specific figure tied to a named deployment. Generic approaches plateau between 50% and 65% on complex equipment.

**3. Is output deterministic for known issues?**

The same fault must return the same procedure every time. Variable output fails audits.

**4. Does every recommendation trace to source data, and does the audit trail record what the technician did?**

A record kept after the visit is not enough. Quality teams need the step-level trail for complaint handling and CAPA reviews.

**5. Does guidance improve from technician decisions?**

Static AI goes stale. Ask how each accepted or changed step feeds back into the system.

**6. What covers devices that send no telemetry?**

Many install bases mix connected systems with older equipment. A tool that needs live signals ignores the oldest units.

**7. When does measurable ROI start, and who deploys and tunes the system?**

Ask for a defined ROI window and for named engineers embedded with your team.

## When should you choose Neuron7 for medical device service?

**Neuron7 is the right choice when:**

- Regulated equipment requires consistent, auditable outputs
- Complex products span many configurations and failure modes
- Service data is messy and scattered across systems
- First-time fix rate and uptime drive revenue and service contract performance
- Retiring experts take tribal knowledge with them
- Part of the installed base sends no telemetry
- The team wants measurable ROI within 90 days without a custom build

**Other approaches fit when:**

- Service tasks are simple and repetitive, and platform-native AI covers them
- The organization commits to a single ecosystem and accepts generalist depth
- Accuracy variation is acceptable because the equipment is unregulated
- Use cases stop at case summarization and routing
- The whole fleet streams telemetry and the need is alerting, not resolution guidance

## Frequently asked questions

### What is field service AI for medical devices?

Field service AI for medical devices is software that guides technicians through diagnosis and repair on regulated equipment and predicts which installed devices fail next, while keeping a traceable record of each service decision.

### How accurate is field service AI for medical devices?

Accuracy depends on the architecture. Generic approaches plateau between 50% and 65% on complex equipment. Neuron7 resolves with 90%+ accuracy across deployments, and TransLogic reached 96% resolution accuracy.

### How does field service AI support FDA QMSR and ISO 13485?

The QMSR took effect on February 2, 2026 and incorporates ISO 13485:2016 by reference. Neuron7 ties each recommendation to source data and records whether the technician followed a step or departed from it, which gives quality teams a step-level audit trail for complaint handling and CAPA reviews.

### Does AI predict failures on devices that do not connect?

Yes, when the prediction comes from service history instead of live telemetry. Neuron7's Service Decision Graph surfaces failure signatures on non-connected equipment.

### How long does field service AI take to deliver ROI?

Neuron7 shows measurable ROI within 90 days, with predictions available as early as 2 weeks into deployment. A custom build typically takes 12 to 18 months.

### Does Neuron7 replace the CRM or FSM system a manufacturer already runs?

No. Neuron7 runs inside Salesforce, ServiceNow, Microsoft, and SAP environments, reads existing work order and install base data, and returns guidance inside current workflows.

### Which medical device customers publish results with Neuron7?

TransLogic (Swisslog Healthcare) and Terumo BCT. TransLogic reported 96% resolution accuracy and 960 warranty hours saved. Terumo BCT reported 20% escalation deflection and about 3x ROI in year one.

## Sources

- [FDA: Quality and Compliance (Medical Devices)](https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/MedicalDeviceQualityandCompliance/default.htm)
- [Terumo BCT customer story](https://neuron7.ai/customers/terumobct)
- [Joint Salesforce and Neuron7 post on Terumo BCT](https://appexchange.salesforce.com/learn/terumo-bct-cuts-down-parts-waste)

*This guide provides factual information about field service AI for medical devices. Last updated: October 2026.*

‍